Loading clinical trials...
Loading clinical trials...
RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a French nationwide network for TET with the objective of territorial coverage by regional expert centers and systematic discussion of patients management at national tumor board.
RYTHMIC (Réseau tumeurs THYMiques et Cancer) is a nationwide network for TET appointed in 2012 by the French National Cancer Institute. The objectives of the network are management of clinical tumor boards and central pathologic review of all cases. RYTHMIC Tumor Board is based on initial histopathological diagnosis. RYTHMIC is a comprehensive tool for research: * to improve the management of patients * to monitor dedicated actions * to screen patients for future translational and clinical trials
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Paris - Institut Curie
Paris, France
Villejuif - Institut Gustave Roussy
Villejuif, France
Start Date
January 1, 2012
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2025
Last Updated
May 24, 2023
3,262
ESTIMATED participants
Lead Sponsor
Intergroupe Francophone de Cancerologie Thoracique
NCT05104736
NCT06311955
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions